2-4-4--6--16--3--2--N-5-111--2--2--3- CRYSTALLINE FORMS OF 2-4-4-ETHOXY-6-OXO-16-DIHYDROPYRIDIN-3-YL-2-FLUOROPHENYL-N-5-111-TRIFLUORO-2-METHYLPROPAN-2-YLISOXAZOL-3-YLACETAMIDE

2-(4-(4-에톡시-6-옥소-1,6-디히드로피리딘-3-일)-2-플루오로페닐)-N-(5-(1,1,1-트리플루오로-2-메틸프로판-2-일)이속사졸-3-일)아세트아미드 및 그를 함유하는 제약 조성물의 신규 결정질 형태가 개시되어 있다. 또한 그의 제조 방법 및 그의 사용 방법이 개시되어 있다. Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	THOMAS JAMES V, CHEUNG MUI, CLARK WILLIAM M, EIDAM HILARY SCHENCK, LAMEY KIMBERLY ANNE
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	THOMAS JAMES V CHEUNG MUI CLARK WILLIAM M EIDAM HILARY SCHENCK LAMEY KIMBERLY ANNE
description	2-(4-(4-에톡시-6-옥소-1,6-디히드로피리딘-3-일)-2-플루오로페닐)-N-(5-(1,1,1-트리플루오로-2-메틸프로판-2-일)이속사졸-3-일)아세트아미드 및 그를 함유하는 제약 조성물의 신규 결정질 형태가 개시되어 있다. 또한 그의 제조 방법 및 그의 사용 방법이 개시되어 있다. Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20170047396A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20170047396A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20170047396A3</originalsourceid><addsrcrecordid>eNqNjEELgkAQhb10iOo_CJ0HXDWj46IrLq07sm7gdomI7RQV2P_qLzZq3WMYZt7jvW8evGNIaSADYLQJQAygYQOMsfGPBzPMjWstV0pqEZZo6jbEMpyqwlbYOQJghwOjkJUrDDbOyEJqKjtFkFIdkMxKaJI_vjVy8ilQE8ephjJck3RKttjxI6qRwHNheS0LsQxm1_Ot96vvXQTrUti8Av98nHz_PF_83b9OexNHbBtF6TbZZTz5L_UBVOJGWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-4-4--6--16--3--2--N-5-111--2--2--3- CRYSTALLINE FORMS OF 2-4-4-ETHOXY-6-OXO-16-DIHYDROPYRIDIN-3-YL-2-FLUOROPHENYL-N-5-111-TRIFLUORO-2-METHYLPROPAN-2-YLISOXAZOL-3-YLACETAMIDE</title><source>esp@cenet</source><creator>THOMAS JAMES V ; CHEUNG MUI ; CLARK WILLIAM M ; EIDAM HILARY SCHENCK ; LAMEY KIMBERLY ANNE</creator><creatorcontrib>THOMAS JAMES V ; CHEUNG MUI ; CLARK WILLIAM M ; EIDAM HILARY SCHENCK ; LAMEY KIMBERLY ANNE</creatorcontrib><description>2-(4-(4-에톡시-6-옥소-1,6-디히드로피리딘-3-일)-2-플루오로페닐)-N-(5-(1,1,1-트리플루오로-2-메틸프로판-2-일)이속사졸-3-일)아세트아미드 및 그를 함유하는 제약 조성물의 신규 결정질 형태가 개시되어 있다. 또한 그의 제조 방법 및 그의 사용 방법이 개시되어 있다. Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.</description><language>eng ; kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170504&DB=EPODOC&CC=KR&NR=20170047396A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170504&DB=EPODOC&CC=KR&NR=20170047396A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>THOMAS JAMES V</creatorcontrib><creatorcontrib>CHEUNG MUI</creatorcontrib><creatorcontrib>CLARK WILLIAM M</creatorcontrib><creatorcontrib>EIDAM HILARY SCHENCK</creatorcontrib><creatorcontrib>LAMEY KIMBERLY ANNE</creatorcontrib><title>2-4-4--6--16--3--2--N-5-111--2--2--3- CRYSTALLINE FORMS OF 2-4-4-ETHOXY-6-OXO-16-DIHYDROPYRIDIN-3-YL-2-FLUOROPHENYL-N-5-111-TRIFLUORO-2-METHYLPROPAN-2-YLISOXAZOL-3-YLACETAMIDE</title><description>2-(4-(4-에톡시-6-옥소-1,6-디히드로피리딘-3-일)-2-플루오로페닐)-N-(5-(1,1,1-트리플루오로-2-메틸프로판-2-일)이속사졸-3-일)아세트아미드 및 그를 함유하는 제약 조성물의 신규 결정질 형태가 개시되어 있다. 또한 그의 제조 방법 및 그의 사용 방법이 개시되어 있다. Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEELgkAQhb10iOo_CJ0HXDWj46IrLq07sm7gdomI7RQV2P_qLzZq3WMYZt7jvW8evGNIaSADYLQJQAygYQOMsfGPBzPMjWstV0pqEZZo6jbEMpyqwlbYOQJghwOjkJUrDDbOyEJqKjtFkFIdkMxKaJI_vjVy8ilQE8ephjJck3RKttjxI6qRwHNheS0LsQxm1_Ot96vvXQTrUti8Av98nHz_PF_83b9OexNHbBtF6TbZZTz5L_UBVOJGWA</recordid><startdate>20170504</startdate><enddate>20170504</enddate><creator>THOMAS JAMES V</creator><creator>CHEUNG MUI</creator><creator>CLARK WILLIAM M</creator><creator>EIDAM HILARY SCHENCK</creator><creator>LAMEY KIMBERLY ANNE</creator><scope>EVB</scope></search><sort><creationdate>20170504</creationdate><title>2-4-4--6--16--3--2--N-5-111--2--2--3- CRYSTALLINE FORMS OF 2-4-4-ETHOXY-6-OXO-16-DIHYDROPYRIDIN-3-YL-2-FLUOROPHENYL-N-5-111-TRIFLUORO-2-METHYLPROPAN-2-YLISOXAZOL-3-YLACETAMIDE</title><author>THOMAS JAMES V ; CHEUNG MUI ; CLARK WILLIAM M ; EIDAM HILARY SCHENCK ; LAMEY KIMBERLY ANNE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20170047396A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>THOMAS JAMES V</creatorcontrib><creatorcontrib>CHEUNG MUI</creatorcontrib><creatorcontrib>CLARK WILLIAM M</creatorcontrib><creatorcontrib>EIDAM HILARY SCHENCK</creatorcontrib><creatorcontrib>LAMEY KIMBERLY ANNE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>THOMAS JAMES V</au><au>CHEUNG MUI</au><au>CLARK WILLIAM M</au><au>EIDAM HILARY SCHENCK</au><au>LAMEY KIMBERLY ANNE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-4-4--6--16--3--2--N-5-111--2--2--3- CRYSTALLINE FORMS OF 2-4-4-ETHOXY-6-OXO-16-DIHYDROPYRIDIN-3-YL-2-FLUOROPHENYL-N-5-111-TRIFLUORO-2-METHYLPROPAN-2-YLISOXAZOL-3-YLACETAMIDE</title><date>2017-05-04</date><risdate>2017</risdate><abstract>2-(4-(4-에톡시-6-옥소-1,6-디히드로피리딘-3-일)-2-플루오로페닐)-N-(5-(1,1,1-트리플루오로-2-메틸프로판-2-일)이속사졸-3-일)아세트아미드 및 그를 함유하는 제약 조성물의 신규 결정질 형태가 개시되어 있다. 또한 그의 제조 방법 및 그의 사용 방법이 개시되어 있다. Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; kor
recordid	cdi_epo_espacenet_KR20170047396A
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title	2-4-4--6--16--3--2--N-5-111--2--2--3- CRYSTALLINE FORMS OF 2-4-4-ETHOXY-6-OXO-16-DIHYDROPYRIDIN-3-YL-2-FLUOROPHENYL-N-5-111-TRIFLUORO-2-METHYLPROPAN-2-YLISOXAZOL-3-YLACETAMIDE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T15%3A20%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=THOMAS%20JAMES%20V&rft.date=2017-05-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20170047396A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true